Picture of Zeria Pharmaceutical logo

4559 — Zeria Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMid CapNeutral

Table: Zeria Pharm - 6-MTH group results

Nov 2 (Reuters)-  
             Zeria Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended       Year to  
                Sep 30, 2017        Sep 30, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             32.41               32.31            68.00     
                 (+0.3 pct)          (+6.5 pct)       (+4.9 pct)   
  Operating          2.39                3.15             5.00     
                 (-24.0 pct)         (+48.9 pct)      (+10.1 pct)  
  Recurring          2.53                3.08             5.00     
                 (-17.8 pct)         (+94.6 pct)      (+12.7 pct)  
  Net                2.13                2.01             3.80     
                 (+6.1 pct)          (+24.1 pct)      (+7.2 pct)   
  EPS             40.70 yen           37.78 yen        74.54 yen   
  Ann Div                             32.00 yen        34.00 yen   
  -Q2 div         17.00 yen           16.00 yen                    
  -Q4 div                             16.00 yen        17.00 yen   
   
  NOTE - Zeria Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Zeria Pharmaceutical

See all news